R Whitehouse

3.4k total citations · 2 hit papers
21 papers, 2.8k citations indexed

About

R Whitehouse is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, R Whitehouse has authored 21 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in R Whitehouse's work include Angiogenesis and VEGF in Cancer (10 papers), Lung Cancer Treatments and Mutations (4 papers) and Breast Cancer Treatment Studies (3 papers). R Whitehouse is often cited by papers focused on Angiogenesis and VEGF in Cancer (10 papers), Lung Cancer Treatments and Mutations (4 papers) and Breast Cancer Treatment Studies (3 papers). R Whitehouse collaborates with scholars based in United Kingdom, Greece and United States. R Whitehouse's co-authors include Adrian L. Harris, Russell Leek, Stephen B. Fox, Michael J. Greenall, Jane B. Clarke, Claire E. Lewis, Kevin C. Gatter, Roy Bicknell, Prudence A. E. Scott and Amir Moghaddam and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer and Annals of Oncology.

In The Last Decade

R Whitehouse

21 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.

1996 1.0k citations Russell Leek, Claire E. Lewis et al. PubMed profile →
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.

1997 700 citations S LeJeune, Prudence A. E. Scott et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R Whitehouse United Kingdom	15	1.7k	1.3k	994	654	348	21	2.8k
Marya F. McCarty United States	29	2.0k 1.2×	1.1k 0.8×	869 0.9×	436 0.7×	285 0.8×	37	3.0k
Christine Kuo United States	28	1.7k 1.0×	1.6k 1.2×	1.2k 1.2×	808 1.2×	287 0.8×	39	3.1k
Sakari Vanharanta United Kingdom	21	2.0k 1.2×	1.6k 1.2×	1.2k 1.2×	691 1.1×	552 1.6×	31	3.7k
Igor Garkavtsev United States	25	2.9k 1.7×	1.2k 0.9×	1.2k 1.2×	273 0.4×	388 1.1×	32	4.1k
Minji Jo United States	23	1.6k 0.9×	796 0.6×	902 0.9×	444 0.7×	203 0.6×	33	2.5k
Marina Holgado-Madruga United States	24	2.4k 1.4×	1.1k 0.8×	378 0.4×	534 0.8×	293 0.8×	33	3.3k
Emilia Fransvea Italy	25	1.5k 0.9×	1.1k 0.8×	730 0.7×	307 0.5×	210 0.6×	33	2.8k
Logan A. Walsh Canada	26	1.7k 1.0×	979 0.7×	1.1k 1.1×	697 1.1×	429 1.2×	55	3.4k
Magne Bryne Norway	33	1.4k 0.8×	1.2k 0.9×	677 0.7×	380 0.6×	359 1.0×	67	3.3k
Eline Menu Belgium	41	2.9k 1.7×	1.4k 1.1×	998 1.0×	796 1.2×	167 0.5×	131	4.3k

Countries citing papers authored by R Whitehouse

Since Specialization

Citations

This map shows the geographic impact of R Whitehouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Whitehouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Whitehouse more than expected).

Fields of papers citing papers by R Whitehouse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Whitehouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Whitehouse. The network helps show where R Whitehouse may publish in the future.

Co-authorship network of co-authors of R Whitehouse

This figure shows the co-authorship network connecting the top 25 collaborators of R Whitehouse. A scholar is included among the top collaborators of R Whitehouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Whitehouse. R Whitehouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaklamanis, L, A P Savage, R Whitehouse, et al.. (1998). Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. British Journal of Cancer. 77(11). 1864–1869. 54 indexed citations

Engels, Knut, Stephen B. Fox, R Whitehouse, Kevin C. Gatter, & Adrian L. Harris. (1997). Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomasin situ of the breast. The Journal of Pathology. 182(4). 414–420. 51 indexed citations

Saunders, Mark, A. J. Salisbury, Kenneth J. O’Byrne, et al.. (1997). A Novel Cyclic Adenosine Monophosphate Analog Induces Hypercalcemia via Production of 1,25-Dihydroxyvitamin D in Patients with Solid Tumors. The Journal of Clinical Endocrinology & Metabolism. 82(12). 4044–4048. 13 indexed citations

Engels, Knut, Stephen B. Fox, R Whitehouse, Kevin C. Gatter, & Adrian L. Harris. (1997). Distinct Angiogenic patterns are associated with high-gradein situ ductal carcinomas of the breast. The Journal of Pathology. 181(2). 207–212. 91 indexed citations

Giatromanolaki, Alexandra, M. Koukourakis, Kenneth J. O’Byrne, et al.. (1997). Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.. PubMed. 16(6B). 3819–25. 58 indexed citations

Fox, Stephen B., Knut Engels, M Comley, et al.. (1997). Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Annals of Oncology. 8(3). 271–275. 54 indexed citations

Koukourakis, Michael I., Alexandra Giatromanolaki, Kenneth J. O’Byrne, et al.. (1997). Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. International Journal of Cancer. 74(6). 565–570. 55 indexed citations

Engels, Knut, Stephen B. Fox, R Whitehouse, K C Gatter, & Adrian L. Harris. (1997). Distinct Angiogenic patterns are associated with high‐grade in situ ductal carcinomas of the breast. The Journal of Pathology. 181(2). 207–212. 8 indexed citations

LeJeune, S, Prudence A. E. Scott, Stephen B. Fox, et al.. (1997). Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.. PubMed. 57(5). 963–9. 700 indexed citations breakdown →

10.

Giatromanolaki, Alexandra, Vassilis G. Gorgoulis, Runjan Chetty, et al.. (1996). C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.. PubMed. 16(2). 987–93. 29 indexed citations

11.

Hochhauser, Daniel, Paul M. Ayton, R Whitehouse, et al.. (1996). Differential expression of the topoisomerase IIα and β genes in human breast cancers. British Journal of Cancer. 73(12). 1518–1524. 60 indexed citations

12.

Giatromanolaki, Alexandra, Kenneth J. O’Byrne, Stephen Fox, et al.. (1996). PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER. The Journal of Pathology. 179(1). 80–88. 148 indexed citations

13.

Kaklamanis, L, Russell Leek, Alexandra Giatromanolaki, et al.. (1996). Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance. British Journal of Cancer. 74(10). 1627–1631. 6 indexed citations

14.

Tarassenko, Lionel, R Whitehouse, Giampietro Gasparini, & Adrian L. Harris. (1996). Neural network prediction of relapse in breast cancer patients. Neural Computing and Applications. 4(2). 105–113. 4 indexed citations

15.

Leek, Russell, Claire E. Lewis, R Whitehouse, et al.. (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.. PubMed. 56(20). 4625–9. 1001 indexed citations breakdown →

16.

Kaklamanis, Loukas, A P Savage, Neil Mortensen, et al.. (1996). EARLY EXPRESSION OF bcl-2 PROTEIN IN THE ADENOMA-CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA. The Journal of Pathology. 179(1). 10–14. 57 indexed citations

17.

Kaklamanis, Loukas, A P Savage, Neil Mortensen, et al.. (1996). EARLY EXPRESSION OF bcl‐2 PROTEIN IN THE ADENOMA–CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIA. The Journal of Pathology. 179(1). 10–14. 5 indexed citations

18.

Fox, Stephen B., Gareth D. H. Turner, Russell Leek, et al.. (1995). The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Research and Treatment. 36(2). 219–226. 50 indexed citations

19.

Fox, Stephen B., Russell Leek, Michael P. Weekes, et al.. (1995). Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis. The Journal of Pathology. 177(3). 275–283. 374 indexed citations

20.

Fox, Stephen B., R Whitehouse, Russell Leek, et al.. (1995). Breast cancer angiogenesis and tamoxifen resistance. Endocrine Related Cancer. 2(1). 97–103. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact